Health
New combination therapy may help fight antimicrobial resistance – News-Medical.Net
An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according…
An inexpensive, FDA-approved drug — cholestyramine — taken in conjunction with an antibiotic prevents the antibiotic from driving antimicrobial resistance, according to new research by scientists at Penn State and the University of Michigan. The team’s findings appear today (Dec. 1) in the journal eLife.
“Antimicrobial resistance is a serious problem that has led to people dying from common bacterial infections,” said Andrew Read, Evan Pugh Professor of Biology and Entomology and director of the…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
General23 hours agoWhy an Australian journalist is teaching meditation in America’s toughest jails
-
Noosa News23 hours ago“There’s No Going Back”: The Grid Meets the Real World in the Initial Trailer for Third ‘TRON’ Movie ‘Ares’
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025